Orion Investment Company’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Orion Investment Company's BIIB Position: Q2 2026 in Review
Orion Investment Company reduced its Biogen (BIIB) stake by 0.1% in Q2 2026, selling an estimated $7.46K and leaving 39,571 shares worth $8.55M. The position accounts for 2.49% of the portfolio, ranked #15.
Orion Investment Company first reported a position in BIIB in Q2 2024 and has held it in 9 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Orion Investment Company held 39,571 shares of Biogen worth $8.55M as of Q2 2026.
- Orion Investment Company sold 39 Biogen shares in Q2 2026, an estimated $7.46K.
- Biogen made up 2.49% of Orion Investment Company's portfolio in Q2 2026, its #15 holding.
- Orion Investment Company first reported a position in Biogen in Q2 2024 and has held it in 9 quarters since.
- 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Orion Investment Company's 13F filing for Q2 2026, filed 11 Aug 2026.